Tradestie Institutional Equity Comparison Engine

NTLA vs AMLX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AMLX Overall Edge

AMLX Captures Institutional Edge (4โ€“0 Pillars ยท 8โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Amylyx Pharmaceuticals, Inc. Common Stock (AMLX) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, NTLA trades at N/M Forward P/E with -826.0% operating margin (-48.0% YoY revenue) versus AMLX at 2.8x Forward P/E and 0.0% operating margin (-99.6% YoY). In options structure, NTLA sits in BREAKDOWN (78th %ile IV; Dealer Gamma Walls on Pro) against AMLX sits in BREAKDOWN (10th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner AMLX
NTLA N/M vs AMLX 2.8x Fwd P/E
Growth & Margin Winner AMLX
Op Margin -826.0% vs 0.0% ยท YoY -48.0% vs -99.6%
Momentum & Technical Winner AMLX
1Y +15.3% vs +127.3% ยท 52W Pos 20% vs 57%
Options & Structure Winner AMLX
BREAKDOWN (78th %ile IV) vs BREAKDOWN (10th %ile IV)
NTLA NASDAQ
Intellia Therapeutics, Inc
In Vitro & In Vivo Diagnostic Substances
$10.00
+3.09% 1D
Market Cap $1.5B
1M Return -12.43%
1Y Return +15.34%
Forward P/E N/M
Unified AI Score
49.9 / 100 HOLD
Tech 47.0 Fund 55.0 Flow 59.0 Mom 60.0
AMLX NASDAQ
Amylyx Pharmaceuticals, Inc. Common Stock
Pharmaceutical Preparations
$28.23
-6.78% 1D
Market Cap $3.8B
1M Return +7.19%
1Y Return +127.33%
Forward P/E 2.8x
Unified AI Score
58.8 / 100 HOLD
Tech 47.0 Fund 52.0 Flow 64.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: NTLA +15.34% AMLX +127.33% Spread: +111.99 pp (AMLX Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period NTLA Revenue AMLX Revenue NTLA Op. Margin AMLX Op. Margin Margin Edge
FY2018 $30M N/A -298.6% N/A NTLA
FY2019 $40M N/A -246.8% N/A NTLA
FY2020 $60M N/A -235.5% N/A NTLA
FY2021 $30M $0M -810.4% -29013.3% NTLA
FY2022 $50M $20M -879.0% -905.7% NTLA
FY2023 $40M $380M -1420.5% 10.2% AMLX
FY2024 $60M $90M -923.1% -360.2% AMLX
FY2025 $70M N/A -651.7% N/A NTLA

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: NTLA (1) vs AMLX (8)
Institutional Metric NTLA AMLX Criterion Row Winner
Market Capitalization Scale $1.5B $3.8B Larger Scale AMLX
Trailing P/E Ratio Valuation N/M 2.8x Lower Multiple AMLX
Forward P/E Ratio Valuation N/M 2.8x Lower Multiple AMLX
Revenue Growth (YoY) Growth -48.0% -99.6% Higher Growth NTLA
Operating Margin (TTM) Profitability -826.0% 0.0% Higher Margin AMLX
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -62.6% -30.1% Higher ROE AMLX
52-Week Range Position Momentum 20% ($8โ€“$18) 57% ($11โ€“$41) Stronger Trend AMLX
Beta / 30D Volatility Risk Regime 2.30ฮฒ ยท 87% Vol 1.16ฮฒ ยท 59% Vol Lower Realized Risk AMLX
Unified Institutional Score Composite Signal 49.9 / 100 (HOLD) 58.8 / 100 (HOLD) Higher Composite AMLX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full NTLA vs AMLX Buy Guide
NTLA BREAKDOWN
94d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 78th %ile
IV Regime Elevated (60thโ€“80th %ile)
Live NTLA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
AMLX BREAKDOWN
61d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 10th %ile
IV Regime Compressed (<25th %ile)
Live AMLX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither NTLA nor AMLX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.